In patients with type 2 diabetes or HF, SGLT2 inhibitors reduce gout-related outcomes. Nabrdalik K, Lip GYH. Ann Intern Med 2023 Nov 7. doi: 10.7326/J23-0081.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nabrdalik K, Lip GYH. In patients with type 2 diabetes or HF, SGLT2 inhibitors reduce gout-related outcomes. Ann Intern Med 2023 Nov 7. doi: 10.7326/J23-0081.
PMID: 37931256